DR-0201
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DR-0201, covering 2024-08-13 to 2024-08-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers [Phase 1]